Hereditary Syndromes with NETs: MEN1/2, VHL Pheochromocytoma /Paraganglioma

September 16, 2020 – September 16, 2021

Target Audience

This activity is designed for health care professionals in the areas of oncology, gastroenterology, pulmonology, surgery, radiology, nurses and allied fields involved with or interested in the use of NETs.

Educational Goal

The purpose of this educational activity is to provide attendees with evidence-based knowledge regarding NETs.

Learning Objectives

  • Explain the strengths and weaknesses of imaging modalities in identifying NETs
  • Discuss the relationships between genetics, immunochemistry and NETs
  • Identify the role of surgery in the treatment and management of NETs
  • Describe the various symptom and medical management therapies of NETs
  • Illustrate the challenges in diagnosing and managing NETs


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutions and North American Neuroendocrine Tumor Society. The CMEsolutions is accredited by the ACCME to provide continuing medical education for physicians.

The CMEsolutions designates this enduring material activity for a maximum of 1 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component and 60% passing on MOC test, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

This nursing continuing professional development activity was approved by the Continuing Nursing Education Group, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Arizona, Idaho and Utah Nurses Associations are member of the Continuing Nurse Education Group. Approved for 1 Contact Hour


There is no registration fee for this activity.

Participation Requirements

  1. Read CME Information
  2. View designated video
  3. Logon to the following URL:
  4. Complete evaluation, credit request form, MOC request, and download or print credit statement

Faculty and Disclosures

Lauren Fishbein, MD, PhD

Associate Professor, University of Colorado School of Medicine
Aurora, CO
Lauren Fishbein has no relevant financial relationships to disclose.

Mark Andrew Lewis, MD
Director Gastrointestinal Oncology, Intermountain Healthcare
Murray, UT
Mark Andrew Lewis has disclosed the following relevant financial relationships: Natera-Advisory Board; Medscape-Distal Content Production

Planner Disclosures

No member of CMEsolutions or North American Neuroendocrine Tumor Society has any relevant financial relationships to disclose in regards to this activity.

Off-label Use

This activity may contain discussion of unlabeled and/or investigational uses of agents not approved by the FDA.  Please consult the prescribing information for each product.

Commercial Support

There is no commercial support for this activity.

Privacy Policy

CMEsolutions Privacy and Confidentiality Policy:
CMEsolutions can be contacted at .

 evaluation/credit request